← Leaderboards
Melissa Leigh Barker-Haliski
University Of Washington
$2,874,971
Attributed
$2,874,971
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $777.5K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,874,971 · 3
By mechanism
R01$1,943,750 · 1
R61$557,732 · 1
R33$373,489 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Heather C. Mefford$10,783,225
- Evan E. Eichler$97,393,877
- Raimondo D'ambrosio$3,970,843
- Murray A Raskind$6,021,327
- Nephi Stella$14,141,128
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMedicalFocal SeizureAffectCorneaEpilepsySeveritiesSeizuresPre-ClinicalChronicDisease ProgressionAmyloid Beta-Protein PrecursorAgedDepositionBeta Amyloid PathologyCytokineDna Sequence AlterationClinical ResearchBehavioralComorbidityAmyloid Beta-ProteinCircadianAssociated SymptomAnxiety-Like Behavior
Grant awards (8)
Investigational WNT-pathway modulators for the treatment and prevention of drug-resistant seizures$373,489
R33 · FY2025 · NS · contact PI
Impact of Chronic Seizures on Neuropsychiatric Comorbidities in AD-Associated Models$388,750
R01 · FY2024 · AG · contact PI
Investigational WNT-pathway modulators for the treatment and prevention of drug-resistant seizures$168,982
R61 · FY2024 · NS · contact PI
Investigational WNT-pathway modulators for the treatment and prevention of drug-resistant seizures$388,750
R61 · FY2023 · NS · contact PI
Impact of Chronic Seizures on Neuropsychiatric Comorbidities in AD-Associated Models$388,750
R01 · FY2023 · AG · contact PI
Impact of Chronic Seizures on Neuropsychiatric Comorbidities in AD-Associated Models$388,750
R01 · FY2022 · AG · contact PI
Impact of Chronic Seizures on Neuropsychiatric Comorbidities in AD-Associated Models$388,750
R01 · FY2021 · AG · contact PI
Impact of Chronic Seizures on Neuropsychiatric Comorbidities in AD-Associated Models$388,750
R01 · FY2020 · AG · contact PI